Key result
Unilateral uptake on adrenal scintigraphy was significantly associated with the persistence and hormonal progression of subclinical Cushing's syndrome (P<0.01).
Why the study?
Does (131)I-6-beta-iodomethylnorcholesterol scintigraphy predict the occurrence of adrenal hyperfunction or mass enlargement in patients with unilateral adrenocortical incidentalomas?
Observational (n=51)
Yes
Does (131)I-6-beta-iodomethylnorcholesterol scintigraphy predict the occurrence of adrenal hyperfunction or mass enlargement in patients with unilateral adrenocortical incidentalomas?
p-value: p=<0.01
Unilateral uptake on adrenal scintigraphy predicts the persistence and progression of subclinical Cushing's syndrome in patients with adrenocortical incidentalomas.
No takes yet. Share an insight, caveat, or question.
Unilateral uptake on IMS was associated with SCS progression; supports risk stratification but leaves open whether scintigraphy should alter follow-up.
Fagour et al. (2008) conducted an observational in adrenocortical incidentalomas (n=51). Unilateral uptake on (131)I-6-beta-iodomethylnorcholesterol scintigraphy was evaluated on Occurrence of adrenal hyperfunction or mass enlargement (p=<0.01). Unilateral uptake on adrenal scintigraphy was significantly associated with the persistence and hormonal progression of subclinical Cushing's syndrome (P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: